Monoclonal Antibodies Targeting the Epidermal Growth Factor Receptor

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|6|3|275-287

ISSN： 1389-4501

Source： Current Drug Targets, Vol.6, Iss.3, 2005-05, pp. : 275-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Epidermal Growth Factor Receptor in Solid Tumors: Critical Evaluation of the Biological Importance of Therapeutic Monoclonal Antibodies

By  

Current Medicinal Chemistry, Vol. 16, Iss. 29, 2009-01 ,pp. : 3797-3804

Bentham Science Publishers

Access to resources Recommend Favorite

The Synergistic Effect of Humanized Monoclonal Antibodies Targeting Insulin-Like Growth Factor 1 Receptor (IGF-1R) and Chemotherapy

By  

Current Drug Targets, Vol. 15, Iss. 7, 2014-06 ,pp. : 674-680

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in the Treatment of Colorectal Cancer: State of the Art

By Diasio Robert B.   Fourie Jeanne  

Drugs, Vol. 66, Iss. 11, 2006-01 ,pp. : 1441-1463

Adis International

Access to resources Recommend Favorite

ZD1839: targeting the epidermal growth factor receptor in cancer therapy

By Herbst Roy S  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 837-849

Informa Healthcare

Access to resources Recommend Favorite

Targeting the epidermal growth factor receptor in solid tumors: focus on safety

By Lucchini Eleonora   Pilotto Sara   Spada Elisa   Melisi Davide   Bria Emilio   Tortora Giampaolo  

Expert Opinion on Drug Safety, Vol. 13, Iss. 5, 2014-05 ,pp. : 535-549

Informa Healthcare

Access to resources Recommend Favorite